ID   BI2L2_HUMAN             Reviewed;         529 AA.
AC   Q6UXY1; B0QYE2; Q96BG7;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   18-JUN-2025, entry version 164.
DE   RecName: Full=BAR/IMD domain-containing adapter protein 2-like 2 {ECO:0000312|HGNC:HGNC:26203};
DE   AltName: Full=Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2;
DE            Short=BAI1-associated protein 2-like protein 2;
DE   AltName: Full=Planar intestinal- and kidney-specific BAR domain protein;
DE            Short=Pinkbar;
GN   Name=BAIAP2L2; ORFNames=UNQ9336/PRO34007;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21743456; DOI=10.1038/nsmb.2079;
RA   Pykalainen A., Boczkowska M., Zhao H., Saarikangas J., Rebowski G.,
RA   Jansen M., Hakanen J., Koskela E.V., Peranen J., Vihinen H., Jokitalo E.,
RA   Salminen M., Ikonen E., Dominguez R., Lappalainen P.;
RT   "Pinkbar is an epithelial-specific BAR domain protein that generates planar
RT   membrane structures.";
RL   Nat. Struct. Mol. Biol. 18:902-907(2011).
CC   -!- FUNCTION: Phosphoinositides-binding protein that induces the formation
CC       of planar or gently curved membrane structures. Binds to
CC       phosphoinositides, including to phosphatidylinositol 4,5-bisphosphate
CC       (PtdIns(4,5)P2) headgroups. There seems to be no clear preference for a
CC       specific phosphoinositide (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21743456};
CC       Peripheral membrane protein {ECO:0000269|PubMed:21743456}. Cell
CC       junction {ECO:0000269|PubMed:21743456}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:21743456}. Note=Localizes to RAB13-positive
CC       vesicles and to the plasma membrane at intercellular contacts.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6UXY1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UXY1-2; Sequence=VSP_021324;
CC   -!- TISSUE SPECIFICITY: Expressed in the epithelial layer of the intestine
CC       (at protein level). {ECO:0000269|PubMed:21743456}.
CC   -!- DOMAIN: The IMD domain consisting of an antiparallel dimer of three-
CC       helix bundles, featuring on one side a positively charged. The N-
CC       terminal alpha-helix inserts into the lipid bilayer. Also forms
CC       homodimers and homooligomers. The residue Trp-141 is essential for
CC       oligomer formation (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY358164; AAQ88531.1; -; mRNA.
DR   EMBL; AL022322; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015619; AAH15619.1; -; mRNA.
DR   CCDS; CCDS43018.1; -. [Q6UXY1-1]
DR   RefSeq; NP_079321.3; NM_025045.5. [Q6UXY1-1]
DR   RefSeq; XP_005261808.1; XM_005261751.5. [Q6UXY1-1]
DR   RefSeq; XP_011528681.1; XM_011530379.4. [Q6UXY1-2]
DR   RefSeq; XP_054181895.1; XM_054325920.1. [Q6UXY1-2]
DR   RefSeq; XP_054181901.1; XM_054325926.1. [Q6UXY1-1]
DR   AlphaFoldDB; Q6UXY1; -.
DR   SMR; Q6UXY1; -.
DR   BioGRID; 123120; 7.
DR   FunCoup; Q6UXY1; 21.
DR   STRING; 9606.ENSP00000371085; -.
DR   GlyGen; Q6UXY1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q6UXY1; -.
DR   PhosphoSitePlus; Q6UXY1; -.
DR   BioMuta; BAIAP2L2; -.
DR   DMDM; 74749434; -.
DR   jPOST; Q6UXY1; -.
DR   MassIVE; Q6UXY1; -.
DR   PaxDb; 9606-ENSP00000371085; -.
DR   PeptideAtlas; Q6UXY1; -.
DR   ProteomicsDB; 67675; -. [Q6UXY1-1]
DR   ProteomicsDB; 67676; -. [Q6UXY1-2]
DR   ABCD; Q6UXY1; 4 sequenced antibodies.
DR   Antibodypedia; 301; 136 antibodies from 25 providers.
DR   DNASU; 80115; -.
DR   Ensembl; ENST00000381669.8; ENSP00000371085.3; ENSG00000128298.18. [Q6UXY1-1]
DR   GeneID; 80115; -.
DR   KEGG; hsa:80115; -.
DR   MANE-Select; ENST00000381669.8; ENSP00000371085.3; NM_025045.6; NP_079321.3.
DR   UCSC; uc003auw.4; human. [Q6UXY1-1]
DR   AGR; HGNC:26203; -.
DR   CTD; 80115; -.
DR   DisGeNET; 80115; -.
DR   GeneCards; BAIAP2L2; -.
DR   HGNC; HGNC:26203; BAIAP2L2.
DR   HPA; ENSG00000128298; Group enriched (intestine, kidney).
DR   MIM; 617536; gene.
DR   OpenTargets; ENSG00000128298; -.
DR   VEuPathDB; HostDB:ENSG00000128298; -.
DR   eggNOG; ENOG502QW6V; Eukaryota.
DR   GeneTree; ENSGT00940000153560; -.
DR   HOGENOM; CLU_025877_1_1_1; -.
DR   InParanoid; Q6UXY1; -.
DR   OMA; QNLMEHF; -.
DR   OrthoDB; 9944156at2759; -.
DR   PAN-GO; Q6UXY1; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; Q6UXY1; -.
DR   PathwayCommons; Q6UXY1; -.
DR   Reactome; R-HSA-9035034; RHOF GTPase cycle.
DR   BioGRID-ORCS; 80115; 14 hits in 1151 CRISPR screens.
DR   ChiTaRS; BAIAP2L2; human.
DR   GenomeRNAi; 80115; -.
DR   Pharos; Q6UXY1; Tbio.
DR   PRO; PR:Q6UXY1; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q6UXY1; protein.
DR   Bgee; ENSG00000128298; Expressed in mucosa of transverse colon and 127 other cell types or tissues.
DR   ExpressionAtlas; Q6UXY1; baseline and differential.
DR   GO; GO:0044291; C:cell-cell contact zone; IDA:UniProtKB.
DR   GO; GO:0071439; C:clathrin complex; IDA:dictyBase.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0012506; C:vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; ISS:UniProtKB.
DR   GO; GO:0051764; P:actin crosslink formation; IBA:GO_Central.
DR   GO; GO:0051017; P:actin filament bundle assembly; IBA:GO_Central.
DR   GO; GO:0061024; P:membrane organization; ISS:UniProtKB.
DR   GO; GO:0007009; P:plasma membrane organization; IEA:InterPro.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IBA:GO_Central.
DR   CDD; cd07644; I-BAR_IMD_BAIAP2L2; 1.
DR   CDD; cd11914; SH3_BAIAP2L2; 1.
DR   FunFam; 1.20.1270.60:FF:000056; brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2; 1.
DR   FunFam; 2.30.30.40:FF:000185; brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2; 1.
DR   Gene3D; 1.20.1270.60; Arfaptin homology (AH) domain/BAR domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR030126; Baiap2l2_I-BAR_dom.
DR   InterPro; IPR013606; I-BAR_dom.
DR   InterPro; IPR027681; IRSp53/IRTKS/Pinkbar.
DR   InterPro; IPR035593; Pinkbar_SH3.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR14206; BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1-ASSOCIATED PROTEIN 2; 1.
DR   PANTHER; PTHR14206:SF5; BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1-ASSOCIATED PROTEIN 2-LIKE PROTEIN 2; 1.
DR   Pfam; PF08397; IMD; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; BAR/IMD domain-like; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS51338; IMD; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   neXtProt; NX_Q6UXY1; -.
DR   PharmGKB; PA142672563; -.
DR   TreeFam; TF325648; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cytoplasmic vesicle;
KW   Lipid-binding; Membrane; Phosphoprotein; Proteomics identification;
KW   Reference proteome; SH3 domain.
FT   CHAIN           1..529
FT                   /note="BAR/IMD domain-containing adapter protein 2-like 2"
FT                   /id="PRO_0000256130"
FT   DOMAIN          1..239
FT                   /note="IMD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00668"
FT   DOMAIN          324..387
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          221..327
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          403..510
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        299..313
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        403..413
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        452..462
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        463..472
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80Y61"
FT   MOD_RES         272
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80Y61"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80Y61"
FT   MOD_RES         478
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80Y61"
FT   MOD_RES         481
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80Y61"
FT   VAR_SEQ         441..454
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_021324"
FT   CONFLICT        252
FT                   /note="C -> R (in Ref. 3; AAH15619)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        411
FT                   /note="M -> MTPM (in Ref. 3; AAH15619)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   529 AA;  58987 MW;  A9D16724F6FCE118 CRC64;
     MAPEMDQFYR STMAIYKSIM EQFNPALENL VYLGNNYLRA FHALSEAAEV YFSAIQKIGE
     RALQSPTSQI LGEILVQMSD TQRHLNSDLE VVVQTFHGGL LQHMEKNTKL DMQFIKDSRQ
     HYELEYRHRA ANLEKCMSEL WRMERKRDKN VREMKESVNR LHAQMQAFVS ESQRAAELEE
     KRRYRFLAEK HLLLSNTFLQ FFGRARGMLQ NRVLLWKEQS EASRSPSRAH SPGLLGPALG
     PPYPSGRLTP TCLDMPPRPL GEFSSPRSRH GSGSYGTEPD ARPASQLEPD RRSLPRTPSA
     SSLYSGSAQS SRSNSFGERP GGGGGARRVR ALVSHSEGAN HTLLRFSAGD VVEVLVPEAQ
     NGWLYGKLEG SSASGWFPEA YVKALEEGPV NPMTPVTPMT SMTSMSPMTP MNPGNELPSR
     SYPLRGSHSL DDLLDRPGNS IAPSEYWDGQ SRSRTPSRVP SRAPSPAPPP LPSSRRSSMG
     STAVATDVKK LMSSEQYPPQ ELFPRGTNPF ATVKLRPTIT NDRSAPLIR
//
